1.
Eandi M. Costo-efficacia dell’amfotericina B liposomiale nella terapia dell’aspergillosi invasiva. Farmeconomia. Health Economics and Therapeutic Pathways. 2004;5(1):47-61. https://doi.org/10.7175/fe.v5i1.786